Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The U.S. Food and Drug Administration has agreed to prioritize a request to expand the use of Tzield to children as young as one year old, currently a…
Sanofi shares ended the trading session on Tuesday, December 30, with a gain of 0.92%, closing at 83 euros after finishing at 82.24 euros the previous…
Sanofi's stock ended the session on Monday, December 29, with a gain of 0.77%, at 82.24 euros, amid a strategic acquisition announced the previous wee…
Sanofi has received a complete response letter from the U.S. FDA regarding its application for marketing authorization of tolebrutinib in the treatmen…
The French pharmaceutical group has signed an agreement to acquire the American company Dynavax Technologies Corporation, specialized in vaccines, acc…
The Japanese Ministry of Health has granted marketing authorization for Dupixent (dupilumab) to treat bronchial asthma in children aged 6 to 11 with s…
The European Commission has approved Wayrilz (rilzabrutinib), a Bruton's tyrosine kinase inhibitor developed by Sanofi, for the treatment of immune th…
Sanofi anticipates delays in the regulatory process for tolébrutinib, a treatment for non-relapsing secondary progressive multiple sclerosis, expected…
Sanofi's stock fell 2.56% to 81.19 euros this Monday midday, following a close at 83.32 euros on Friday. The pharmaceutical company announced that the…
